Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05912348 · ClinicalTrials.gov registry record · NA
The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults
A NA study of Obesity and Insulin Resistance, sponsored by University of New Hampshire.
- Recruiting
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT05912348: Recruiting NA study of Obesity and Insulin Resistance, sponsored by University of New Hampshire.
NCT05912348 is a NA study of Obesity and Insulin Resistance that is actively recruiting participants, run by University of New Hampshire. The registered enrollment target is 45 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05912348, a NA study of Obesity and Insulin Resistance, is actively recruiting participants, sponsored by University of New Hampshire.
- RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial aims to learn about the alterations in insulin resistance and metabolic flexibility following a transition to an obesogenic lifestyle in fit young men and women. The main questions it aims to answer are: 1. Does adding excess carbohydrates when transitioning to a sedentary lifestyle promote insulin resistance and impaired 24hr glucose regulation in healthy men and women? 2. Does adding excess carbohydrates when transitioning to a sedentary lifestyle lower the body's ability to break down fats and carbohydrates in healthy men and women? 3. Does the added physical activity blunt shifts in carbohydrate and fat oxidation in healthy men and women?
Primary Outcome
We will use HOMA-IR to measure changes in insulin resistance across the 4 study groups
Conditions Studied
Interventions
- BEHAVIORAL Low Physical Activity and Added Carbohydrate Group
- BEHAVIORAL Low physical Activity Control
- BEHAVIORAL High Physical Activity and Added Carbohydrate Group
Study Locations (1)
New Hampshire
- University of New Hampshire Cardiometabolic Research Laboratory - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2023-02-08 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What NCT05912348 shows while recruiting
NCT05912348 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower).
The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Low Physical Activity and Added Carbohydrate Group is the first listed.
NCT05912348 reports a single indexed study location in New Hampshire.
Frequently Asked Questions
What is clinical trial NCT05912348 about?
NCT05912348 is a clinical study titled "The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults". This clinical trial aims to learn about the alterations in insulin resistance and metabolic flexibility following a transition to an obesogenic lifestyle in fit young men and women. The main questions it aims to answer are: 1. Does adding excess carbohydrates when transitioning to a sedentary lifes...
What is the current status of trial NCT05912348?
This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2023-02-08. Estimated completion is 2026-09-30.
What conditions does trial NCT05912348 study?
This clinical trial studies the following conditions: Obesity, Insulin Resistance, Impaired Glucose Tolerance, Metabolic Disturbance.
What interventions are being tested in trial NCT05912348?
The interventions under investigation include: Low Physical Activity and Added Carbohydrate Group (BEHAVIORAL), Low physical Activity Control (BEHAVIORAL), High Physical Activity and Added Carbohydrate Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT05912348?
This trial is sponsored by University of New Hampshire, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05912348 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05912348's enrollment target sits among peer trials
45 752nd of 1053 higher than 295 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI